Connecticut Children's Medical Center Settles With DOJ, Agrees to End Gender Treatment for Minors

Connecticut Children's Medical Center has agreed to permanently stop providing gender-transition medical treatment to minors as part of a settlement announced Wednesday by the Department of Justice.

The Hartford-based hospital will not give puberty blockers, cross-sex hormones, or other gender-transition-related drugs to any patient under 18, according to DOJ. It must also maintain written policies banning such care for minors going forward.

The settlement requires CT Children's to set up a $500,000 fund covering medical care for former patients seeking what DOJ described as detransition services. The hospital will also pay a civil penalty to resolve separate allegations that it improperly billed insurers for the treatments, according to Hartford Business Journal. The exact penalty amount wasn't disclosed by either DOJ or the hospital.

CT Children's denied all the allegations. The hospital wasn't found liable for anything — this is a settlement, not a verdict.

A Program Already Winding Down

This wasn't a surprise pivot. CT Children's announced in July 2025, roughly a year before this settlement, that it would phase out its pediatric gender-care program entirely, citing what it called an increasingly complex legal and regulatory environment. The hospital had already stopped starting new patients on puberty blockers or hormone therapy and was transitioning existing patients to other providers.

So the DOJ settlement formalizes a policy CT Children's had largely put in place on its own. Yale New Haven Health, the other major Connecticut health system that ran pediatric gender-care services, also announced last year it would stop providing puberty blockers and hormone therapy to minors.

Part of a Bigger DOJ Push

CT Children's is the third pediatric hospital system to reach this kind of deal with the Justice Department, following settlements with Texas Children's Hospital and the Cleveland Clinic Foundation. DOJ says the effort is tied to President Trump's executive orders targeting gender-transition medical care for minors.

Associate Attorney General Stanley Woodward framed the settlement as a warning shot beyond just this one hospital. "The Department of Justice will stop at nothing to protect America's children," Woodward said in a statement, adding that the resolution should remind "hospitals, medical providers, and pharmaceutical companies" that DOJ will "vigorously enforce federal law" where children's lives are at stake.

Assistant Attorney General Brett Shumate, who leads the Civil Division, credited CT Children's for cooperating. "As with Texas Children's and Cleveland Clinic before it, I am encouraged when leading institutions like Connecticut Children's agree to be part of the solution and no longer the problem," Shumate said. He added DOJ isn't done. "We cannot and will not rest in our pursuit of justice for the victims of these discredited practices."

DOJ said CT Children's earned credit for cooperation by being "cooperative, proactive, and solution-driven" throughout the investigation, and specifically pointed to the $500,000 restorative-care commitment as evidence of that.

The Hospital's Response

CT Children's kept its public comment tight. In a statement to Hartford Business Journal, the hospital said the resolution "allows our organization to remain focused on our mission of improving the health and well-being of children." It emphasized that patient privacy was protected throughout. "We were able to resolve this matter without disclosing any protected patient information to the U.S. government."

The hospital said it has complied and will keep complying with federal and state law, and declined further comment.

What's Actually Contested Here

Supporters of pediatric gender-transition care argue these treatments, when used under established clinical guidelines, help reduce distress for adolescents diagnosed with gender dysphoria. Major medical organizations have historically endorsed individualized treatment plans. This is the position CT Children's and Yale New Haven Health operated under for years before regulatory and legal pressure mounted.

DOJ's counter-position, reflected in the settlement terms, is that these treatments amount to what officials call "sex-mutilating drugs" causing lasting harm, and that insurance billing practices around them violated federal law. Those are allegations resolved by settlement, not proven in court. CT Children's denies them.

Breitbart's coverage of the settlement leaned heavily on DOJ's framing, including its "sex-mutilating drugs" language, without noting that the hospital had already been winding the program down for a year before the settlement was finalized. Hartford Business Journal's reporting captured that timeline detail, which matters for understanding how much this settlement changed versus formalized.

No criminal charges have been filed against CT Children's. This is a civil settlement. The exact dollar figure of the insurance-billing penalty remains undisclosed, and whether DOJ pursues similar deals with other Connecticut providers, or with hospitals in other states that haven't yet wound down these programs, is the open question going forward.